OGN vs STEL · P/E 3.4, rev $3.02B vs P/E 18, $1.91B cap
Organon & Co (OGN) versus Stellar Bancorp, Inc. (STEL) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Stellar Bancorp, Inc. (STEL) is a banks - regional company listed on US.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
STEL does not have a complete income-statement cache yet.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. STEL currently screens at market cap $1.91B and trailing P/E 18.2.
Not investment advice. Open the OGN and STEL stock pages for the full models.
Not investment advice.